Kyle R. Noll, Ph.D.
Department of Neuro-Oncology, Division of Cancer Medicine
About Dr. Kyle R. Noll
Kyle Noll, PhD, is a clinical neuropsychologist and associate professor in the Department of Neuro-Oncology. He provides comprehensive neuropsychological assessment for patients with cancer-related cognitive, emotional, and behavioral changes. He also offers interventions and assists with treatment planning to ameliorate or prevent cognitive and behavioral difficulties in adult cancer patients. He also serves as a supervisor to neuropsychology fellows within the Section of Neuropsychology's postdoctoral training program and to rotating trainees from other Texas Medical Center institutions. Noll's research activities focus on understanding contributors to neurocognitive dysfunction in patients with primary brain tumors, including relationships between tumor, genetic, and sociodemographic characteristics. Noll joined MD Anderson in 2015.
Read More
Present Title & Affiliation
Primary Appointment
Associate Professor, Multi-Year Award (Sep 2024-Sep 2027), Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor, Department of Neuro-Oncology, Section of Neuropsychology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2011 | The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, US, unknown, Ph.D., Clinical Psychology, Neuropsychology Emphasis |
| 2007 | New York University, New York, New York, US, unknown, MA, Psychology |
| 2004 | The University of Texas at Austin, Austin, Texas, US, unknown, BA, Philosophy |
Postgraduate Training
| 2013-2014 | Research Fellow, Clinical Neuropsychology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2011-2013 | Postdoctoral Fellow, Clinical Neuropsychology, Baylor College of Medicine, Houston, Texas |
Licenses & Certifications
| 2017 | American Board of Professional Psychology Certified in Clinical Neuropsychology |
| 2013 | Texas State Board of Examiners of Psychologists |
Experience & Service
Faculty Academic Appointments
Assistant Professor, Department of Neuro-Oncology, Section of Neuropsychology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2022
Extramural Institutional Committee Activities
Member, MD Anderson Faculty Senate, The University of Texas MD Anderson Cancer Center, 2020 - 2023
Clinical Stakeholder, MD Anderson IO Toxicity, The University of Texas MD Anderson Cancer Center, 2020 - Present
Neuropsychology Lead, MD Anderson Interdisciplinary Awake Craniotomy Team, The University of Texas MD Anderson Cancer Center, 2018 - Present
Member, MD Anderson Psychologists Credentialing Committee, The University of Texas MD Anderson Cancer Center, 2017 - Present
Editorial Activities
Neuro-Oncology Practice Associate Editor, 8888, 2023 - Present
Honors & Awards
| 2025 | Acute, Intensive, Residential Service SIG of Society of Clinical Child & Adolescent Psychology Outstanding Poster Award |
| 2025 - Present | American Brain Tumor Association Young Investigator Award |
| 2010 | National Academy of Neuropsychology Student Poster Award |
| 2007 | MA Scholar Distinction, New York University |
| 2004 | Phi Beta Kappa, The University of Texas at Austin |
| 2002 | Hibbs Award for Philosophical Writing, The University of Texas at Austin |
Professional Memberships
Selected Presentations & Talks
Local Presentations
- 2025. Chemotherapy-related brain network changes in breast cancer. Conference. Oral presentation, Cancer Systems Imaging Retreat. Houston, Texas, US.
- 2025. Accuracy of task-based electrocorticography brain mapping and relationships with postoperative cognitive-linguistic changes following eloquent glioma resection. Conference. Cancer Survivorship Retreat, Oral presentation. Houston, Texas, US.
- 2019. Maximizing Cognitive Functioning. Conference. Oral Presentation, Together In Hope: A Conference for Brain Tumor Patients and their Families. Houston, TX, US.
- 2019. Brain Health and Cognitive Function. Conference. Oral Presentation, 2nd MD Anderson Brain Metastases Scientific Retreat, The University of Texas M. D. Anderson Cancer Center. Houston, TX, US.
- 2018. Neuropsychological practice in the oncology setting. Conference. The University of Texas M. D. Anderson Cancer Center. Houston, TX, US.
- 2018. Cognitive function and cancer survivorship. Conference. The University of Texas M. D. Anderson Cancer Center. Houston, TX, US.
- 2017. Language mapping, neurocognitive functioning, and quality of life in patients with glioma. Conference. Oral presentation, meeting of the Cancer Survivorship Research Workgroup, The University of Texas M. D. Anderson Cancer Center. Houston, TX, US.
- 2017. Neuropsychological practice in the oncology setting. Conference. Oral presentation at the Psychiatry Educational Lecture Series, The University of Texas M. D. Anderson Cancer Center. Houston, TX, US.
- 2016. Maximizing brain health in patients with cancer: the importance of neuroprotection and neurorestoration. Conference. Oral presentation at the Advances in Oncology Seminar, The University of Texas M. D. Anderson Cancer Center Grand Rounds (Chair Jim Ray, PhD). Houston, TX, US.
- 2014. Quality of life, mood, and neurocognitive functioning in patients with temporal lobe glioma. Conference. The University of Texas M.D. Anderson Cancer Center. Houston, TX, US.
- 2014. A brain-plasticity based computerized intervention to treat attention and memory problems in adult brain tumor survivors. Conference. UT MD Anderson Cancer Center. Houston, TX, US.
- 2014. Relationships between tumor grade and neurocognitive functioning in patients with glioma of the left temporal lobe. Conference. The University of Texas M.D. Anderson Cancer Center. Houston, TX, US.
- 2009. Philosophy, neuroscience, and the law. In M. Gottlieb (Chair), Is fMRI ready for primetime?: Ethical and legal controversies. Conference. Symposium held at the annual meeting of the Texas Psychological Association. Houston, TX, US.
Regional Presentations
- 2022. Psychology's role in primary care: new developments and trends for the future. Conference. Texas Psychological Association. Dallas, TX, US.
- 2021. Assessment of neurocognitive function and outcome. Conference. The University of Texas MD Anderson Cancer Center Image Guided Cancer Therapy Seminar, US.
- 2021. Panelist. Conference. Department of Pediatrics Grand Rounds, The University of Texas MD Anderson Cancer Center, Virtual, US.
- 2021. Neurocognitive functioning and brain tumors. Conference. Oral Presentation, The University of Texas MD Anderson Cancer Center Core Curriculum Lecture Series, Virtual, US.
- 2006. Relationships between social behavior and cognitive function in psychiatric inpatients. Conference. Poster session presented at the annual New York University Graduate Research Conference. New York, NY, US.
National Presentations
- 2025. Developing patient-specific functional atlases with inverse distance weighting of MR images. Invited. Poster presentation, Annual meeting & exhibition of the American Association of Physicists in Medicine. washington, DC, US.
- 2025. A longitudinal study identifying adolescents at risk for acute psychiatric rehospitalization: a two-year survivor analysis. Invited. Poster presentation, Meeting of the Society of Clinical Child and Adolescent Psychology. Chicago, IL, US.
- 2025. Deaf patient with glioma: fMRI and awake craniotomy. Invited. Oral presentation, Webinar of the American Society of Functional Neuroradiology; Virtual, US.
- 2025. Treating cancer-related neurocognitive impairment and strategies to cope with change. Invited. Oral presentation, Meeting of the North American Skull Base Society (NASBS) and 9th World Federation of Skull Base Societies (WFSBS). New Orleans, LA, US.
- 2024. Characterizing neurotoxicity associated with systemic chemotherapy in patients with breast cancer using domain-specific intra-individual neurocognitive variability. Invited. Oral presentation, Annual scientific meeting of the Society for Neuro-oncology. Houston, TX, US.
- 2024. Mapping language processing in surgical glioma patients. Invited. Oral presentation, Annual scientific meeting of the Society for Neuro-oncology. Houston, TX, US.
- 2024. Neurocognitive outcome following awake craniotomy for insular glioma resection: impact of surgical approach and tumor classification. Invited. Poster presentation, Annual scientific meeting of the Society for Neuro-oncology. Houston, TX, US.
- 2024. Relationships between intraoperative task-based gamma band electrocorticograms, direct electrical stimulation, and cognitive-linguistic outcome following awake brain tumor resection. Invited. Poster presentation, Annual scientific meeting of the Society for Neuro-oncology. Houston, TX, US.
- 2024. Distinct connectomic features associate with neurocognitive function and functional independence following resection of eloquent gliomas. Invited. Oral presentation, meeting of the Congress of Neurological Surgeons. Houston, TX, US.
- 2024. Electrocorticogram (ECoG) gamma-band modulations induced by cognitive-linguistic tasks for intraoperative functional language mapping during awake craniotomy. Invited. Oral presentation, meeting of the Congress of Neurological Surgeons. Houston, TX, US.
- 2024. Neurocognitive outcome following awake craniotomy in elderly patients with high grade gliomae glioma. Invited. Interactive poster presentation, meeting of the Congress of Neurological Surgeons. Houston, TX, US.
- 2024. Correspondence between intraoperative gamma band electrocorticograms and direct electrical stimulation across diverse naming tasks in patients with language-eloquent brain tumors. Invited. Poster presentation, Annual scientific meeting of the Society for Neuro-oncology. Houston, TX, US.
- 2024. Clinicians, patients, & researchers: a live discussion about successful research partnerships. Invited. Oral presentation, American Speech-Language-Hearing Special Interest Group, Professional Development Hour; Virtual, US.
- 2023. Gamma-band modulations of electrocorticogram (ECoG) induced by cognitive-linguistic tasks during awake craniotomy. Invited. Poster presentation at the annual meeting of the Congress of Neurological Surgeons. Washington, DC, US.
- 2023. Intraoperative language mapping utilizing gamma-band modulations of electrocorticogram (ECoG) induced by cognitive-linguistic tasks with different levels of complexities: comparison with reproducible speech arrests induced by DCS. Invited. Poster presentation at the annual meeting of the Congress of Neurological Surgeons. Washington, DC, US.
- 2023. Automated detection of resting-state language network in brain tumor patients using independent component analysis with MRI-derived templates. Invited. Oral presentation at the 65th Annual Meeting & Exhibition of the American Association of Physicists in Medicine. Houston, TX, US.
- 2023. Assessing spatial similarity between primary language areas of brain templates with those detected from presurgical fmri of brain tumor patients. Invited. Oral presentation at the meeting of the American Society of Neuroradiology. Chicago, IL, US.
- 2023. Preoperative structural and functional imaging correlates of aphasic surgical deficits. Invited. Oral presentation at the meeting of the American Association of Neurological Surgeons. Los Angeles, CA, US.
- 2022. Intraoperative cognitive-linguistic mapping guided by visualization of gamma band modulation electrocorticograms: proof of concept in a patient with a left temporal and occipital low-grade astrocytoma. Invited. Poster presentation at the 27th Annual Meeting of the Society for Neuro-Oncology Scientific Meeting. Tampa Bay, FL, US.
- 2022. Intraoperative language mapping using gamma-band modulations of electrocorticogram (ECoG) induced by word/sound categorization task: validation with reproducible speech arrests during linguistic tasks. Invited. Poster presentation at the 27th Annual Meeting of the Society for Neuro-Oncology Scientific Meeting. Tampa Bay, FL, US.
- 2022. Peri-operative neurocognitive functioning in low grade glioma. Invited. Oral presentation at the Clinica Alemana: VII Neuro-Oncology Course: A Comprehensive Vision of Disease, Virtual Meeting, US.
- 2021. Alterations in structural connectomic properties associated with neurocognitive changes following glioma resection. Invited. Oral Presentation to the Society for Neuro-Oncology Maximal Safe Brain Tumor Resection: Intraoperative Visualization and the Connectome Conference. Virtual, US.
- 2019. Evaluation of brain normalization methods and their effect on the construction of functional connectomics in patients with glioma. Invited. Oral Presentation at the 61st Annual Meeting and Exhibition of the American Association of Physicists in Medicine. San Antonio, TX, US.
- 2019. Alterations in functional connectomics associated with neurocognitive changes following brain tumor resection. Invited. Rapid oral presentation at the 7th meeting of the Intraoperative Imaging Society. Houston, TX, US.
- 2019. Seed-based resting-state fMRI analysis for preoperative language mapping: A data-driven approach for guiding the seed selection. Invited. Rapid oral presentation at the 7th meeting of the Intraoperative Imaging Society. Houston, TX, US.
- 2018. Intra-individual neurocognitive variability in patients with cancer: a predictor and marker of neurotoxicity associated with chemotherapy?. Invited. Poster presentation at the 20th Annual Meeting of the Society for Neuro-Oncology Scientific Meeting. New Orleans, LA, US.
- 2018. Functional connectome analysis of fMRI before and after brain tumor resection. Invited. Oral presentation at the 60th Annual Meeting of the American Association of Physicians in Medicine Meeting. Nashville, TN, US.
- 2017. Accuracy of presurgical functional MR imaging for language mapping of brain tumors: a systematic review and meta-analysis. Invited. Poster session, meeting of the American Society of Neuroradiology. Long Beach, CA, US.
- 2015. Neurocognitive changes associated with frontal lobectomy for right and left frontal lobe glioma. Invited. Poster presentation at the 20th Annual Meeting of the Society for Neuro-Oncology Scientific Meeting. San Antonio, TX, US.
- 2015. Lower brain network efficiency in IDH1 wild type (IDH1-WT) malignant astrocytoma compared to IDH1 mutant (IDH1-M). Invited. Poster presentation at the 20th Annual Meeting of the Society for Neuro-Oncology Scientific Meeting. San Antonio, TX, US.
- 2015. Relationships between tumor compartment volumes and neurocognitive functioning in patients with temporal lobe glioma. Invited. Oral presentation at the 20th Annual Meeting of the Society for Neuro-Oncology Scientific Meeting. San Antonio, TX, US.
- 2015. Tumor volumetric and textural feature predictors of neurocognitive impairment in patients with temporal lobe glioma. Invited. Oral presentation at the 20th Annual Meeting of the Society for Neuro-Oncology Scientific Meeting. San Antonio, TX, US.
- 2014. Depression and executive functioning in relation to survival among patients with glioblastoma. Invited. Platform presentation at the Scientific Meeting and Education Day of the Society for Neuro-Oncology. Miami, FL, US.
- 2014. Neurocognitive changes associated with surgical resection of right and left temporal lobe glioma. Invited. Poster session presented at the annual meeting of the Congress of Neurological Surgeons. Boston, MA, US.
- 2014. Predictors of quality of life in multiple sclerosis: Relationships between cognitive, physical, and subjective measures of disease burden. Invited. Poster session presented at the 12th annual American Academy of Clinical Neuropsychology conference. New York, NY, US.
- 2011. Comparison of short and standard form CVLT-II performances in a demyelinating disease population. Invited. Poster session presented at the 31st annual meeting of the National Academy of Neuropsychology. Marco Island, FL, US.
- 2011. Lack of the PASAT, SDMT, or Judgment of Line Tests to detect cognitive impairment in a cohort with demyelinating disease. Invited. Poster session presented at the 63rd annual meeting of the American Academy of Neurology. Honolulu, HI, US.
International Presentations
- 2025. Structural changes in brain networks and depression severity in chemotherapy-treated breast cancer. Invited. Oral presentation, Meeting of the Organization for Human Brain Mapping. Brisbane, AU.
- 2025. Deducing resting-state fmri seeds with manifold learning and distance clustering. Invited. Poster presentation, Meeting of the International Society for Magnetic Resonance in Medicine. Honolulu, US.
- 2025. Towards data-driven tractography for surgical planning. Invited. Poster presentation, Meeting of the International Society for Magnetic Resonance in Medicine. Honolulu, US.
- 2025. A tablet-based testing platform to map patients' cognitive functions during awake craniotomy. Invited. Oral presentation, Meeting of the European Low-Grade Glioma Network. Bern, CH.
- 2025. Predictors of cognitive concerns in older women with breast cancer: results from a prospective longitudinal observational trial. Invited. Poster presentation, Meeting of the International Cognition and Cancer Task Force. Caen, FR.
- 2025. Relationships between intraoperative gamma band electrocorticograms, direct electrical stimulation, and cognitive-linguistic outcomes in patients with language eloquent brain tumors. Invited. Poster presentation, Meeting of the International Cognition and Cancer Task Force. Caen, FR.
- 2025. Predictors of cognitive changes in older women with breast cancer: results from a prospective longitudinal observational trial. Invited. Poster presentation, Meeting of the International Cognition and Cancer Task Force. Caen, FR.
- 2025. Accelerated brain aging in breast cancer survivors: grey matter alterations post-chemotherapy. Invited. Oral presentation, Meeting of the International Cognition and Cancer Task Force. Caen, FR.
- 2025. Influence of tractography seeding and thresholding upon relationships between surgical trauma to white matter tracts and postoperative neurocognitive outcome following resection of language-eloquent glioma. Invited. Oral presentation, Meeting of the International Cognition and Cancer Task Force. Caen, FR.
- 2025. Validity related evidence for CogState tasks in patients with brain metastases. Invited. Poster presentation, Meeting of the International Neuropsychological Society. New Orleans, US.
- 2025. An exploratory factor analysis of the Beck Depression Inventory–Second Edition and associations of symptom clusters with biopsychosocial factors and quality of life in newly diagnosed primary brain tumor patients. Invited. Poster presentation, Meeting of the International Neuropsychological Society. New Orleans, US.
- 2025. The neurobiological footprint of breast cancer chemotherapy: gray matter changes and signs of accelerated brain aging. Invited. Oral presentation, Meeting of the International Neuropsychological Society. New Orleans, US.
- 2024. Validity related evidence for CogState tasks in patients with brain metastases. Invited. Poster presentation, Meeting of the European Association of Neuro-Oncology. Glasgow, GB.
- 2024. ECoG gamma-band modulations induced by cognitive-linguistic tasks during awake craniotomy. Invited. Poster presentation, Meeting of the Organization for Human Brain Mapping. Seoul, KR.
- 2024. Non-invasive mapping predicts language outcomes after eloquent tumor resection. Invited. Oral and poster presentation, Meeting of the Organization for Human Brain Mapping. Seoul, KR.
- 2024. Resting-state fMRI localization of tongue motor areas with a patient-based probabilistic functional atlas. Invited. Poster presentation, Meeting of the International Society for Magnetic Resonance in Medicine, SG.
- 2024. Probabilistic template matching for detection of language network with resting-state fMRI in patients with brain tumors. Invited. Oral presentation, Power Pitch at the meeting of the International Society for Magnetic Resonance in Medicine, SG.
- 2023. Neurocognitive rehabilitation in brain tumors. Invited. Santiago, CL.
- 2023. Neurocognitive impact of brain tumors and therapy. Invited. Oral presentation, Workshop at the Clinica Alemana: VIII Neuro Oncology Course. Santiago, CL.
- 2023. Gamma-band modulations of electrocorticogram (ECoG) induced by cognitive-linguistic tasks during awake craniotomy for feasible functional language mapping. Invited. Poster presentation, Meeting of the Society for Neuro-Oncology. Vancouver, CA.
- 2023. Functional MRI and DTI tractography as adjuncts to improve the predictive value of TMS for cortical language sites. Invited. Oral presentation, Meeting of the Society for Neuro-Oncology. Vancouver, CA.
- 2023. Baseline patient-reported outcomes in an ongoing phase III trial of pre-operative SRS versus post-operative SRS for brain metastases. Invited. Poster presentation, Meeting of the Society for Neuro-Oncology. Vancouver, CA.
- 2023. Neurocognitive function and neurocognitive concerns in an ongoing phase III trial of pre-operative SRS versus post-operative SRS for brain metastases. Invited. Poster presentation, Meeting of the Society for Neuro-Oncology. Vancouver, CA.
- 2023. Development and implementation of a novel, brief neurocognitive screening and rehabilitation service in a clinical neuro-oncology setting. Invited. Poster presentation, Meeting of the Society for Neuro-Oncology. Vancouver, CA.
- 2023. Variability in anxiety and depression symptoms after eloquent glioma resection is associated with changes in functional connectomic properties. Invited. Oral presentation, Meeting of the Society for Neuro-Oncology. Vancouver, CA.
- 2023. Changes in functional connectivity after surgery are associated with decline in functional independence in patients with eloquent glioma. Invited. Oral presentation, Meeting of the Society for Neuro-Oncology. Vancouver, CA.
- 2023. Probability of mapping primary language areas with clinical paradigms used in presurgical fMRI of brain tumor patients. Invited. Poster presentation at the International Society for Magnetic Resonance in Medicine Workshop on Current Issues in Brain Function. Padua, IT.
- 2023. Neurocognitive function and neurocognitive concerns in an ongoing phase III trial of pre-operative SRS versus post-operative SRS for brain metastases. Invited. Poster presentation at the SNO/ASCO CNS Cancer Conference. San Francisco, US.
- 2023. Clinical functional MRI-derived probabilistic template of primary language areas of patients with brain tumors. Invited. Poster presentation at the ISMRM & ISMRT Annual Meeting & Exhibition. Toronto, CA.
- 2023. Understanding object dysnomia in patients with left hemisphere primary brain tumors. Invited. Poster presentation at the meeting of the International Cognition and Cancer Task Force. San Diego, US.
- 2023. Resting motor threshold is associated with neurocognitive function and supports global oscillatory state alterations in low grade glioma patients. Invited. Poster presentation at the meeting of the International Cognition and Cancer Task Force. San Diego, US.
- 2022. Neurocognitive decline in patients with 4-20 brain metastases treated with stereotactic radiosurgery. Invited. Poster session, Mid-Year Meeting of the International Neuropsychological Society. Barcelona, ES.
- 2021. Cerebrovascular reactivity mapping using resting-state functional MRI in patient with gliomas. Invited. Poster presentation at the International Society for Magnetic Resonance in Medicine Virtual Conference and Exhibition, Online, US.
- 2021. Associations between clinical improvement, length of stay, and rehospitalization following inpatient early intervention. Invited. Poster presented at the Congress of the Schizophrenia International Research Society, Virtual, US.
- 2020. Simulation of postsurgical functional connectome from presurgical resting-state fMRI: optimization and validation. Invited. Poster presentation at the International Society for Magnetic Resonance in Medicine Virtual Conference and Exhibition, Online, US.
- 2019. Evaluation of brain normalization methods in glioma patients. Invited. Poster Presentation at the Annual Meeting of the Organization for Human Brain Mapping. Rome, IT.
- 2019. Semantic fluency performance is predictive of rehospitalization in patients with recent onset psychosis. Invited. Poster presentation at the annual meeting of the Schizophrenia International Research Society. Orlando, US.
- 2018. Combining regional homogeneity and meta-analysis to improve preoperative language mapping with resting-state functional MRI. Invited. E-poster presentation at the Scientific Session of the Joint Annual Meeting ISMRM-ESMRMB. Paris, FR.
- 2017. Driver safety in patients with primary brain tumors. Invited. Poster session, meeting of the International Neuropsychological Society. New Orleans, US.
- 2016. Longitudinal changes in cognitive function in patients with colorectal carcinoma. Invited. Poster session at the meeting of the International Cognition and Cancer Task Force. Amsterdam, NL.
- 2015. Neurocognitive functioning, gender, and inflammatory markers in patients with colorectal cancer prior to chemotherapy. Invited. Poster session presented at the 43rd annual meeting of the International Neuropsychological Society. Denver, US.
- 2013. Verbal learning and encoding strategies in patients with glioma of the right and left temporal lobes. Invited. Poster session presented at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology held in conjunction with the Scientific Meeting and Education Day of the Society for Neuro-Oncology. San Francisco, US.
- 2013. Neurocognitive functioning and functional status in patients with glioma of the temporal lobes. Invited. Poster session presented at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology held in conjunction with the Scientific Meeting and Education Day of the Society for Neuro-Oncology. San Francisco, US.
- 2013. Neurocognitive functioning in patients with glioma of the right and left temporal lobes. Invited. Poster session presented at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology held in conjunction with the Scientific Meeting and Education Day of the Society for Neuro-Oncology. San Francisco, US.
- 2013. Quality of life, mood, and neurocognitive functioning in patients with temporal lobe glioma. Invited. Poster session presented at the 4th Quadrennial Meeting of the World Federation of Neuro-Oncology held in conjunction with the Scientific Meeting and Education Day of the Society for Neuro-Oncology. San Francisco, US.
- 2012. Relationships between retinal nerve fiber thickness and cognitive and motor functioning in multiple sclerosis. Invited. Poster session presented at the 40th annual meeting of the International Neuropsychological Society. Montreal, CA.
- 2012. Test-retest reliability and practice effects of the Symbol Digit Modality Test in patients with demyelinating disease. Invited. Poster session presented at the 40th annual meeting of the International Neuropsychological Society. Montreal, CA.
- 2012. An alternate form of the Texas Card Sorting Test: A pilot study. Invited. Poster session presented at the 40th annual meeting of the International Neuropsychological Society. Montreal, CA.
- 2011. Dyadic Short Forms of the Wechsler Adult Intelligence Scales-IV for Estimating FSIQ and GAI. Invited. Poster session presented at the 39th annual meeting of the International Neuropsychological Society. Boston, US.
- 2010. Normative Data for Logical Memory Story A in Alzheimer’s Disease and Normal Controls. Invited. Poster session presented at the 30th annual meeting of the National Academy of Neuropsychology. Vancover, CA.
- 2010. Victoria Stroop test performance in multiple sclerosis, Parkinson’s disease, and Alzheimer’s disease. Invited. Poster session presented at the 38th annual meeting of the International Neuropsychological Society. Acapulco, MX.
Formal Peers
- 2025. Glioma and cognition: impact of anti-tumor treatment and mitigation and rehabilitation approaches, Oral presentation, US.
- 2024. Glial brain tumors, cognition, and quality of life Oral presentation,, US.
- 2023. Neuropsychological outcomes of glioma and treatment: assessment and management, Oral presentation. Houston, Texas, US.
- 2023. Noll K. Neuropsychology of glioma, Oral presentation. Invited, US.
- 2021. Cognitive functioning and associated functional deficits in patients with glioma, Oral presentation. Invited, US.
- 2021. Noll K. Neurocognition, mood, and quality of life in patients with glioma. Invited, US.
- 2021. Noll K, Anderson K, Warner A, Ugueto A. Preparing for board certification in professional psychology. Invited, US.
- 2021. Noll K. Neuropsychology of glioma, Oral presentation. Invited, US.
- 2019. Noll K. Cognitive-linguistic brain mapping in glioma patients, Oral presentation. Invited. Houston, TX, US.
- 2018. Noll K, Booth J, Harik L, Cirino P. Finding a job in neuropsychology: a panel discussion, Oral presentation. Invited. Houston, TX, US.
- 2018. Noll K. Intraoperative brain mapping in patients with brain tumors, Oral presentation. Invited. Houston, TX, US.
- 2016. Noll K. Consciousness: The mind-body problem and mental causation, Oral presentation. Invited. Houston, TX, US.
- 2013. Noll K. Cognitive rehabilitation of the executive functions. In H. Thomas (Chair), Uniting rehabilitation for growth in education, Oral presentation. Invited. Houston, TX, US.
Grant & Contract Support
| Date: | 2025 - 2027 |
| Title: | MRI of aquaporin activity as a marker of glymphatic function in glioma patients before and after surgery |
| Funding Source: | Advanced Research Projects Agency for Health (ARPA-H |
| Role: | Co-PI |
| Date: | 2025 - Present |
| Title: | A randomized controlled trial to assess the impact of live and recorded music-based interventions on pre-operative stress, mood, pain and biomarkers, in neurosurgical patients (Music-STAR Trial: NCT06536504) |
| Funding Source: | Cancer Neuroscience Program Shark Tank of The University of Texas MD Anderson Cancer Center |
| Role: | Co-PI |
| Date: | 2025 - 2027 |
| Title: | MRI of aquaporin activity as a marker of glymphatic function in glioma patients before and after surgery |
| Funding Source: | Advanced Research Projects Agency for Health |
| Role: | Co-I |
| Date: | 2025 - 2028 |
| Title: | Advancing connectomics-based prediction of postoperative neurocognitive outcome in patients with eloquent glioma |
| Funding Source: | University Cancer Foundation via the Institutional Research Grant program at The University of Texas MD Anderson Cancer Center |
| Role: | PI |
| Date: | 2025 - Present |
| Title: | Predictive multimodal mapping of language-eloquent brain to improve surgical planning and postoperative outcomes in glioma patients |
| Funding Source: | Cancer Prevention and Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| Date: | 2025 - Present |
| Title: | Multimodal language mapping in glioma: validating passive auditory ECOG for predicting outcomes and guiding resection |
| Funding Source: | Elsa Pardee Foundation |
| Role: | Co-I |
| Date: | 2024 - Present |
| Title: | Advancing prediction of postoperative neurocognitive outcomes through simulation of surgery-induced alterations in brain connectomes in patients with eloquent glioma |
| Funding Source: | NIH/NCI, 1R03CA289851-01/A1 |
| Role: | Co-PI |
| Date: | 2024 - Present |
| Title: | Neurophysiological impact of prescribed music intervention on cancer patients and providers—a quantitative and qualitative investigation using proteomic and metabolomic profiling, real-time EEG, fMRI, single-cell RNA sequencing, and validated questionnaires |
| Funding Source: | Cancer Neuroscience Program Grant Program of The University of Texas MD Anderson Cancer Center |
| Role: | Co-I |
| Date: | 2022 - 2027 |
| Title: | A comprehensive clinical fMRI software solution to enable mapping of critical functional networks and cerebrovascular reactivity in the brain |
| Funding Source: | NIH/NCI |
| Role: | Co-I |
| ID: | 1R01CA258788-01A1 |
| Date: | 2018 |
| Title: | Simulation of surgery-induced changes in brain connectomics and prediction of cognitive outcomes in patients with IDH1-mutant glioma |
| Funding Source: | Cancer Prevention & Research Institute of Texas (CPRIT) |
| Role: | Co-I |
| Date: | 2016 - 2018 |
| Title: | Resting-state functional MRI in glioma patients before and after surgery |
| Funding Source: | The University of Texas M.D. Anderson Cancer Center Diagnostic Imaging Clinical Research Committee |
| Role: | Co-I |
| Date: | 2016 - 2018 |
| Title: | Language mapping, neurocognitive functioning, and quality of life in patients with glioma |
| Funding Source: | The University of Texas M.D. Anderson Cancer Center Survivorship Research Seed Grant |
| Role: | PI |
Selected Publications
Peer-Reviewed Articles
- Bander Evan D, Noll Kyle R, Andrade de Almeida Romulo A, Seaman Scott C, Matei B, Clark Victoria E, Dima S, Wefel Jeffrey S, Mariana B, Sherise F, Weinberg Jeffrey S, Lang Frederick F, Prabhu Sujit S. Relationships Between Surgical Approach, Tumor Classification Scheme, and Early Neurocognitive Outcome After Awake Craniotomy for Resection of Insular Glioma. Operative Neurosurgery(10):1227/ons.0000000000001767, 2025. e-Pub 2025.
- Noll KR, Wefel JS. Characterization, etiology, and management of neurocognitive impairment in patients with glioma: an evidentiary update. Curr Opin Neurol, 2025. PMID: 40948080.
- Noll KR. Language mapping during awake brain surgery in a deaf patient with a brain tumor: illustrative case. J Neurosurg Case Lessons 9(18):CASE2597, 2025. e-Pub 2025. PMID: 40324327.
- Silva E, Noll K, Bradshaw M, Connelly K, Liu HL, Tummala R, Ferson D, Lang FF, Kumar VA. Language mapping during awake brain surgery in a deaf patient with a brain tumor: illustrative case. Journal of Neurosurgery: Case Lessons 5(9):18, 2025. e-Pub 2025.
- Cummings LR, Noll KR, Warner AR, Dickstein D, Ugueto AM. A Longitudinal Study Identifying Adolescents at Risk for Acute Psychiatric Rehospitalization: A 2-Year Survivor Analysis. Evidence-Based Practice in Child and Adolescent Mental Health(16):1-5, 2025. e-Pub 2025.
- Noll KR, Bander ED, Chen HS, Bradshaw M, Wefel JS, Kumar VA, Prabhu SS, Liu H. Changes in functional connectivity are associated with functional independence in the early postoperative period following awake surgical resection of language-eloquent glioma. Neuro-Oncology Advances:vdaf192, 2025. e-Pub 2025.
- Noll KR, Bander ED, Chen HS, Bradshaw M, Wefel JS, Kumar VA, Prabhu SS, Liu H. Changes in functional connectivity are associated with functional independence in the early postoperative period following awake surgical resection of language-eloquent glioma. Neuro-Oncology Advances, 2025. e-Pub 2025.
- Asman P, Tasnim I, Muir M, Hall M, Noll K, Prinsloo S, Pellizzer G, Bhavsar S, Tummala S, Ince N, Prabhu S. Intraoperative Cortical Sensorimotor Mapping During Glioma Resection Monitored With Drum Playing During Awake Craniotomy: A Case Report. Case Reports in Oncological Medicine 2025(1):4625899, 2025. e-Pub 2025.
- Teo JM, Kumar VA, Lee J, Eldaya RW, Hou P, Jen ML, Noll KR, Wei P, Ferguson SD, Prabhu SS, Wintermark M, Liu HL. Probabilistic Presurgical Language Functional MRI Atlas of Brain Tumor Patients. AJNR Am J Neuroradiol. e-Pub 2024. PMID: 38889968.
- Sheppard DP, Noll KR, Wefel JS, Bradshaw ME. Neuropsychological evaluation for oncology. Neurol Clin. e-Pub 2024.
- Lee J, Kumar VA, Teo JM, Eldaya RW, Hou P, Noll KR, Ferguson SD, Prabhu SS, Liu HL. Comparative analysis of brain language templates with primary language areas detected from presurgical fMRI of brain tumor patients. Brain Behav 14(6):e3497, 2024. e-Pub 2024. PMID: 38898620.
- Noll KR, Bradshaw M, Sheppard D, Wefel JS. Perioperative Neurocognitive Function in Glioma Surgery. Curr Oncol Rep 26(5):466-76, 2024. e-Pub 2024.
- Noll KR, Asman P, Tasnim I, Hall M, Connelly K, Swamy C, Ene C, Tummala S, Grasu RM, Liu HL, Kumar VA, Muir M, Prinsloo S, Michener H, Wefel JS, Ince NF, Prabhu SS. Intraoperative language mapping guided by real-time visualization of gamma band modulation electrocorticograms: Case report and proof of concept. Neurooncol Pract 11(1):92-100, 2024. e-Pub 2024. PMID: 38222047.
- Noll KR, Asman P, Tasnim I, Hall M, Connelly K, Swamy C, Ene C, Tummala S, Grasu RM, Liu HL, Kumar VA. Intraoperative language mapping guided by real-time visualization of gamma band modulation electrocorticograms: Case report and proof of concept. Neurooncol Pract 11(1):92-100. e-Pub 2024. PMID: 38222047.
- Catalino MP, Noll KR, Wefel JS, Michener H, Prinsloo S, Tummala S, Prabhu S. Decoding the clinical effects of low-grade glioma-induced cortical excitability. J Neurosurg 7(1):1-9, 2023. e-Pub 2023. PMID: 37439490.
- Yeh MY, Chen HS, Hou P, Kumar VA, Johnson JM, Noll KR, Prabhu SS, Ferguson SD, Schomer DF, Peng HH, Liu HL. Cerebrovascular Reactivity Mapping Using Resting-State Functional MRI in Patients With Gliomas. J Magn Reson Imaging 56(6):1863-1871, 2022. e-Pub 2022. PMID: 35396789.
- Connelly K, Gurd L, Noll KR, Prabhu S, Kumar VA, Hutcheson KA. A framework for integrating speech-language pathology in an interdisciplinary awake craniotomy program for brain tumor resection. Perspect ASHA Special Interest Groups. e-Pub 2022.
- Noll KR, Wefel J. On the classification of impairment in neuropsychological research and practice in the neuro-oncological setting. Neurooncol Pract 9(4):255-256, 2022. e-Pub 2022. PMID: 35859538.
- Muir M, Patel R, Traylor J, de Almeida Bastos DC, Prinsloo S, Liu HL, Noll K, Wefel J, Tummala S, Kumar V, Prabhu S. Validation of Non-invasive Language Mapping Modalities for Eloquent Tumor Resection: A Pilot Study. Front Neurosci 16:833073, 2022. e-Pub 2022. PMID: 35299624.
- Chen HS, Kumar VA, Johnson JM, Chen MM, Noll KR, Hou P, Prabhu SS, Schomer DF, Liu HL. Effect of brain normalization methods on the construction of functional connectomes from resting-state functional MRI in patients with gliomas. Magn Reson Med 86(1):487-498, 2021. e-Pub 2021. PMID: 33533052.
- Quirarte JA, Kumar VA, Liu HL, Noll KR, Wefel JS, Lang FF. Language supplementary motor area syndrome correlated with dynamic changes in perioperative task-based functional MRI activations: case report. J Neurosurg 134(6):1-5, 2021. e-Pub 2020. PMID: 32502992.
- Noll KR, Chen HS, Wefel JS, Kumar VA, Hou P, Ferguson SD, Rao G, Johnson JM, Schomer DF, Suki D, Prabhu SS, Liu HL. Alterations in functional connectomics associated with neurocognitive changes following glioma resection. Neurosurgery 88(3):544-551, 2021. e-Pub 2021. PMID: 33080024.
- Kumar VA, Heiba IM, Prabhu SS, Chen MM, Colen RR, Young AL, Johnson JM, Hou P, Noll K, Ferguson SD, Rao G, Lang FF, Schomer DF, Liu HL. The role of resting-state functional MRI for clinical preoperative language mapping. Cancer Imaging 20(1):47, 2020. e-Pub 2020. PMID: 32653026.
- Hsu AL, Chen HS, Hou P, Wu CW, Johnson JM, Noll KR, Prabhu SS, Ferguson SD, Kumar VA, Schomer DF, Chen JH, Liu HL. Presurgical resting-state functional MRI language mapping with seed selection guided by regional homogeneity. Magn Reson Med 84(1):375-383, 2020. e-Pub 2020. PMID: 31793025.
- Estevis E, Noll KR, Bradshaw ME, Wefel JS. Driver safety in patients with primary brain tumors. Neurooncol Pract 6(6):490-498, 2019. e-Pub 2019. PMID: 31832220.
- Noll KR, Sullaway CM, Wefel JS. Depressive symptoms and executive function in relation to survival in patients with glioblastoma. J Neurooncol 142(1):183-191, 2019. e-Pub 2019. PMID: 30680509.
- Noll KR, Bradshaw ME, Weinberg JS, Wefel JS. Neurocognitive functioning is associated with functional independence in newly diagnosed patients with temporal lobe glioma. Neurooncol Pract 5(npx028):184-193, 2018. e-Pub 2018. PMID: 30094046.
- Hsu AL, Hou P, Johnson JM, Wu CW, Noll KR, Prabhu SS, Ferguson SD, Kumar VA, Schomer DF, Hazle JD, Chen JH, Liu HL. IClinfMRI software for integrating functional MRI techniques in presurgical mapping and clinical studies. Front Neuroinform 12:11, 2018. e-Pub 2018. PMID: 29593520.
- Weng HH, Noll KR, Johnson JM, Prabhu SS, Tsai YH, Chang SW, Huang YC, Lee JD, Yang JT, Yang CT, Tsai YH, Yang CY, Hazle JD, Schomer DF, Liu HL. Accuracy of Presurgical Functional MR Imaging for Language Mapping of Brain Tumors: A Systematic Review and Meta-Analysis. Radiology 286(2):512-23, 2018. e-Pub 2018. PMID: 28980887.
- Noll KR, Bradshaw ME, Weinberg JS, Wefel JS. Relationships between neurocognitive functioning, mood, and quality of life in patients with temporal lobe glioma. Psychooncology 26(5):617-624, 2017. e-Pub 2017. PMID: 26677053.
- Kesler SR, Noll K, Cahill DP, Rao G, Wefel JS. The effect of IDH1 mutation on the structural connectome in malignant astrocytoma. J Neurooncol 131(3):565-574, 2017. e-Pub 2017. PMID: 27848136.
- Wefel JS, Noll KR, Rao G, Cahill DP. Neurocognitive function varies by IDH1 genetic mutation status in patients with malignant glioma prior to surgical resection. Neuro Oncol 18(12):1656-1663, 2016. e-Pub 2016. PMID: 27576872.
- Noll KR, Ziu M, Weinberg JS, Wefel JS. Neurocognitive functioning in patients with glioma of the left and right temporal lobes. J Neurooncol 128(2):323-31, 2016. e-Pub 2016. PMID: 27022915.
- Wefel JS, Noll KR, Scheurer ME. Neurocognitive functioning and genetic variation in patients with primary brain tumours. Lancet Oncol 17(3):e97-108, 2016. e-Pub 2016. PMID: 26972863.
- Noll KR, Weinberg JS, Ziu M, Wefel JS. Verbal Learning Processes in Patients with Glioma of the Left and Right Temporal Lobes. Arch Clin Neuropsychol 31(1):37-46, 2016. e-Pub 2016. PMID: 26537777.
- Noll KR, Weinberg JS, Ziu M, Benveniste RJ, Suki D, Wefel JS. Neurocognitive Changes Associated With Surgical Resection of Left and Right Temporal Lobe Glioma. Neurosurgery 77(5):777-85, 2015. e-Pub 2015. PMID: 26317672.
- Noll KR, Sullaway C, Ziu M, Weinberg JS, Wefel JS. Relationships between tumor grade and neurocognitive functioning in patients with glioma of the left temporal lobe prior to surgical resection. Neuro Oncol 17(4):580-7, 2015. e-Pub 2015. PMID: 25227126.
- Wefel JS, Kesler SR, Noll KR, Schagen SB. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J Clin 65(2):123-38, 2015. e-Pub 2015. PMID: 25483452.
Invited Articles
- Noll K, King AL, Dirven L, Armstrong TS, Taphoorn MJB, Wefel JS. Neurocognition and health-related quality of life among patients with brain tumors. Hematol Oncol Clin North Am 36(1):269-282, 2022. e-Pub 2022. PMID: 34711455.
- Noll KR, Walbert T, Wefel JS. Impaired neurocognitive function in glioma patients: from pathophysiology to novel intervention strategies. Curr Opin Neurol 33(6):716-722, 2020. e-Pub 2020. PMID: 33009006.
- Noll KR, Bradshaw ME, Rexer J, Wefel JS. Neuropsychological Practice in the Oncology Setting. Arch Clin Neuropsychol 33(3):344-353, 2018. e-Pub 2018. PMID: 29718081.
Review Articles
- Sheppard, D, Noll, KR, Wefel, JS, Bradshaw, ME. Neuropsychological Evaluation for Oncology. Neurologic Clinics 42(4):875-887, 2024. e-Pub 2024. PMID: 39343481.
- Noll KR, Bradshaw M, Sheppard D, Wefel JS. Perioperative Neurocognitive Function in Glioma Surgery. Curr Oncol Rep 26(5):466-476, 2024. e-Pub 2024. PMID: 38573439.
- Noll KR, Bradshaw ME, Parsons MW, Dawson EL, Rexer J, Wefel JS. Monitoring of Neurocognitive Function in the Care of Patients with Brain Tumors. Curr Treat Options Neurol 21(7):33, 2019. e-Pub 2019. PMID: 31250277.
Other Articles
- Noll KR Commentary: Presurgical Identification of Patients With Glioblastoma at Risk for Cognitive Impairment at 3-Month Follow-up. Neurosurgery. PMID: 32511696.
- Wefel JS, Noll KR, Rao G, Cahill DP Reply to Freyschlag et al. Neuro Oncol 19(4):598-599, 2017. PMID: 28339696.
- Wefel JS, Noll KR Therapies for cognitive deficits associated with chemotherapy for breast cancer: a systematic review of objective outcomes Morean DF, O'Dwyer L, Cherney LR. Breast Diseases 27(2):158-9, 2016.
- Noll KR, Wefel JS Response to "From histology to neurocognition: the influence of tumor grade in glioma of the left temporal lobe on neurocognitive function". Neuro Oncol 17(10):1421-2, 2015. PMID: 26395063.
- Noll KR, Fardell JE Commentary: "Neuropsychological Assessment of Individuals with Brain Tumor: Comparison of Approaches Used in the Classification of Impairment". Front Oncol 5:188, 2015. PMID: 26347854.
Abstracts
- Bander ED, Noll KR, Chen HS, Bradshaw M, Wefel JS, Kumar VP, Prabhu SS, Anthony Liu HL. Distinct Connectomic Features Associate With Neurocognitive Function and Functional Independence Following Resection of Eloquent Gliomas. Neurosurgery 71(Supplement_1):50. e-Pub 2025.
- Noll K, Tasnim I, Asman P, Swamy C, Connelly K, Muir M, Hall M, Pellizzer G, Ince N, Prabhu S. RELATIONSHIPS BETWEEN INTRAOPERATIVE TASK-BASED GAMMA BAND ELECTROCORTICOGRAMS, DIRECT ELECTRICAL STIMULATION, AND COGNITIVE-LINGUISTIC OUTCOME FOLLOWING AWAKE BRAIN TUMOR RESECTION. NEURO-ONCOLOGY 26, 2024. e-Pub 2024.
- Sheppard D, Noll K, Sullaway C, Wefel J. CHARACTERIZING NEUROTOXICITY ASSOCIATED WITH SYSTEMIC CHEMOTHERAPY IN PATIENTS WITH BREAST CANCER USING DOMAIN-SPECIFIC INTRA-INDIVIDUAL NEUROCOGNITIVE VARIABILITY. NEURO-ONCOLOGY 26. e-Pub 2024.
- Noll K, Bander ED, de Almeida RA, Seaman S, Banu M, Clark VE, Suki D, Wefel JS, Bradshaw M, Ferguson S, Weinberg JS. NEUROCOGNITIVE OUTCOME FOLLOWING AWAKE CRANIOTOMY FOR INSULAR GLIOMA RESECTION: IMPACT OF SURGICAL APPROACH AND TUMOR CLASSIFICATION. Neuro-Oncology 26(Supplement_8):viii231. e-Pub 2024.
- Noll K, Tasnim I, Asman P, Swamy C, Connelly K, Muir M, Hall M, Pellizzer G, Ince N, Prabhu S. CORRESPONDENCE BETWEEN INTRAOPERATIVE GAMMA BAND ELECTROCORTICOGRAMS AND DIRECT ELECTRICAL STIMULATION ACROSS DIVERSE NAMING TASKS IN PATIENTS WITH LANGUAGE-ELOQUENT BRAIN TUMORS. Neuro-Oncology 26(Supplement_8):viii232, 2024. e-Pub 2024.
- Wefel JS, Tawbi HA, Sulman EP, Sullaway CM, Thomas AL, Noll KR, Tang C, Ferrarotto R, Welsh J, Guha-Thakurta N, Glitza IC. VALIDITY RELATED EVIDENCE FOR COGSTATE TASKS IN PATIENTS WITH BRAIN METASTASES. NEURO-ONCOLOGY 26:V65-V65. e-Pub 2024.
- Sheppard D, Goldberg M, McGranahan T, Graber J, Venur V, Figuracion KC, Song YB, Wefel J, Noll K, Ferreira M, Halasz L, Taylor L. Development and implementation of a novel, brief neurocognitive screening and rehabilitation service in a clinical neuro-oncology setting. Neuro-Oncology 25(Supplement_5):v163, 2023. e-Pub 2023.
- Wefel J, Noll K, Rao G, Ferguson S, Tawbi H, Huse J, Johnson J, Court L, O'Brien B, Lang F, Ejezie L, Sullaway C, Thomas A, Suki D, Yeboa DN. Neurocognitive function and neurocognitive concerns in an ongoing phase III trial of pre-operative SRS versus post-operative SRS for brain metastases. Neuro-oncol Adv Suppl 3(iii37), 2023. e-Pub 2023.
- Muir M, Prinsloo S, Noll K, Kumar V, Traylor J, Prabhu S. Functional MRI and DTI tractography as adjuncts to improve the predictive value of TMS for cortical language sites. Neuro Oncol 25(Suppl 5):v193-194, 2023. e-Pub 2023.
- Noll KR, Bradshaw M, Chen HS, Wefel JS, Sullaway C, Thomas A, Kumar VA, Prabhu S, Liu HL. Changes in functional connectivity after surgery are associated with decline in functional independence in patients with eloquent glioma. Neuro Oncol 25(Suppl 5):v248. e-Pub 2023.
- Tasnim I, Asman P, Swamy CP, Hall M, Noll K, Connelly K, Tummala S, Ince NF, Prabhu S. Gamma-band modulations of electrocorticogram (ECoG) induced by cognitive-linguistic tasks during awake craniotomy for feasible functional language mapping. Neuro Oncol 25(Suppl 5):v200, 2023. e-Pub 2023.
- Bradshaw M, Wefel J, Noll K, Rao G, Ferguson S, Tawbi H, Huse J, Johnson J, Court L, O'Brien B, Lang F, Ejezie L, Sullaway C, Thomas A, Suki D, Yeboa DN. Baseline patient-reported outcomes in an ongoing phase III trial of pre-operative srs versus post-operative srs for brain metastases. Neuro Oncol 25(Suppl 5):v213, 2023. e-Pub 2023.
- Noll KR, Chen HS, Bradshaw M, Wefel JS, Sullaway C, Thomas A, Kumar VA, Prabhu S, Liu HL. Variability in anxiety and depression symptoms after eloquent glioma resection is associated with changes in functional connectomic properties. Neuro Oncol 25(Suppl 5):v248, 2023. e-Pub 2023.
- Muir M, Noll K, Prinsloo S, Traylor J, Liu HL, Kumar V, Prabhu S. MAPPING LANGUAGE PROCESSING IN SURGICAL GLIOMA PATIENTS. NEURO-ONCOLOGY 26, 2022. e-Pub 2022.
- Prabhu Sujit S, Israt T, Priscella A, Matthew H, Prakash SC, Matthew M, Pellizzer Giuseppe NKR, Nuri I. Electrocorticogram (ECoG) Gamma-band Modulations Induced by Cognitive-Linguistic Tasks for Intraoperative Functional Language Mapping During Awake Craniotomy. Neurosurgery 71(Supplement_1):127, 2022. e-Pub 2022.
- Noll K, Asman P, Connelly K, Tasnim I, Swamy C, Ene C, Tummala S, Grasu R, Liu HL, Kumar V, Muir M, Prinsloo S, Michener H, Wefel J, Ince N, Prabhu. Intraoperative cognitive-linguistic mapping guided by visualization of gamma band modulation electrocorticograms: proof of concept in a patient with left temporal and occipital low-grade astrocytoma. Neuro Oncol 24(Suppl 7):viii200, 2022. e-Pub 2022.
- Tasnim I, Ince N, Prabhu S, Noll K, Swamy C, Connelly K, Asman P, Tummala S, Prinsloo S, Ene C, Grasu R, Liu H, Muir M, Bhavsar S, Kumar V. Intraoperative language mapping using gamma-band modulations of electrocorticogram (ECoG) induced by word/sound categorization task: validation with reproducible speech arrests during linguistic tasks 24(Supp 7):vii 178-vii179, 2022. e-Pub 2022.
- Noll K, Asman P, Connelly K, Tasnim I, Swamy C, Ene C, Tummala S, Grasu R, Liu HL, Kumar V, Muir M, Prinsloo S, Michener H, Wefel J, Ince N, Prabhu. Intraoperative cognitive-linguistic mapping guided by visualization of gamma band modulation electrocorticograms: proof of concept in a patient with left temporal and occipital low-grade astrocytoma 24(Supp 7):vii200, 2022. e-Pub 2022.
- Tasnim I, Ince N, Prabhu S, Noll K, Swamy C, Connelly K, Asman P, Tummala S, Prinsloo S, Ene C, Grasu R, Liu H, Muir M, Bhavsar S, Kumar V. Intraoperative language mapping using gamma-band modulations of electrocorticogram (ECoG) induced by word/sound categorization task: validation with reproducible speech arrests during linguistic tasks. Neuro Onc 24(Supp 7):vii 178-vii179, 2022. e-Pub 2022.
- Noll K, Mitchell D, Chen H, Wefel J, Kumar V, Hou P, Ferguson S, Rao G, Johnson J, Schomer D, Prabhu S, Liu HL. Alterations in structural connectomic properties associated with neurocognitive changes following glioma resection 23(Supp 6):vi225, 2021. e-Pub 2021.
- Noll K, Mitchell D, Chen H, Wefel J, Kumar V, Hou P, Ferguson S, Rao G, Johnson J, Schomer D, Prabhu S, Liu HL. Alterations in structural connectomic properties associated with neurocognitive changes following glioma resection. Neuro Oncl 23(Supp 6):vi225, 2021. e-Pub 2021.
- Yeh M, Gates E, Hou P, Kumar V, Johnson J, Noll K, Prabhu S, Ferguson S, Rao G, Schomer D, Liu HL. Cerebrovascular reactivity mapping using resting-state functional MRI in patient with gliomas. Medical Physics 47(6):E518, 2020. e-Pub 2020.
- Warner A, Noll K. Semantic fluency performance is predictive of re-hospitalization in patients with recent onset psychosis 56(Suppl 2):S223, 2019. e-Pub 2019.
- Warner A, Noll K. Semantic fluency performance is predictive of re-hospitalization in patients with recent onset psychosis. Schizophrenia Bulletin 56(Suppl 2):S223, 2019. e-Pub 2019.
- Sheppard D, Noll K, Wefel J. Intra-individual neurocognitive variability in patients with cancer: a predictor and marker of neurotoxicity associated with chemotherapy? 20(Suppl 6):v173, 2018. e-Pub 2018.
- Sheppard D, Noll K, Wefel J. Intra-individual neurocognitive variability in patients with cancer: a predictor and marker of neurotoxicity associated with chemotherapy? 20(Suppl 6, v173), 2018. e-Pub 2018.
- Chen H, Noll K, Prabhu S, Kumar V, Hou P, Ferguson S, Rao G, Bradshaw M, Johnson J, Schomer D, Liu HL. Functional connectome analysis of FMRI before and after brain tumor resection. Medical Physics 45(6):E368, 2018. e-Pub 2018.
- Noll K, Estevis E, Bradshaw M, Wefe J, Kesler S, Rexer J, Harmon C, Rhines S. Driver safety in patients with primary brain tumors 23(Suppl 1):v157, 2017. e-Pub 2017.
- Noll K, Estevis E, Bradshaw M, Wefe J, Kesler S, Rexer J, Harmon C, Rhines S. Driver safety in patients with primary brain tumors 23(Suppl 1):v157, 2017. e-Pub 2017.
- Noll KR, Narang S, Martinez J, Rao G, Wefel J, Rao A. Tumor volumetric and textural feature predictors of neurocognitive impairment in patients with temporal lobe glioma. Neuro-Oncology 17(Suppl 5):v148, 2015. e-Pub 2015.
- Noll K, Garbarino A, Turner C, Verhaak AMS, Wefel J. Depression and executive functioning in relation to survival among patients with glioblastoma. Neuro-Oncology 16(Suppl 5):v136, 2015. e-Pub 2015.
- Kesler S, Noll K, Cahill D, Rao G, Wefel J. Lower brain network efficiency in IDH1 wild type (IDH1-WT) malignant astrocytoma compared to IDH1 mutant (IDH1-M) 17(Suppl 5, v163), 2015. e-Pub 2015.
- Noll KR, Narang S, Martinez J, Rao G, Wefel J, Rao A. Relationships between tumor compartment volumes and neurocognitive functioning in patients with temporal lobe glioma 17(Suppl 5, v148), 2015. e-Pub 2015.
- Noll KR, Narang S, Martinez J, Rao G, Wefel J, Rao A. Tumor volumetric and textural feature predictors of neurocognitive impairment in patients with temporal lobe glioma 17(Suppl 5, v148), 2015. e-Pub 2015.
- Kesler S, Noll K, Cahill D, Rao G, Wefel J. Lower brain network efficiency in IDH1 wild type (IDH1-WT) malignant astrocytoma compared to IDH1 mutant (IDH1-M). Neuro-Oncology 17(Suppl 5):v163, 2015. e-Pub 2015.
- Noll, Wang X, Shi Q, Wefel J. Neurocognitive functioning, gender, and inflammatory markers in patients with colorectal cancer prior to chemotherapy 21(Suppl 1):292, 2015. e-Pub 2015.
- bradshaw ME, Noll K, Ziu M, Weinberg J, Strange C, Turner C, Wefel JS. Neurocognitive functioning and functional status in patients with glioma of the temporal lobes. Neuro-Oncology 15(Suppl 3):iii92, 2015. e-Pub 2015.
- Noll KR, Wang, X, Shi, Q, Wefel, J. Neurocognitive functioning, gender, and inflammatory markers in patients with colorectal cancer prior to chemotherapy. Journal of the International Neuropsychological Society 21(Suppl 1):292, 2015. e-Pub 2015.
- Demeriva P, Noll KR, Sellin J, Prabhu S, Wefel J. Neurocognitive changes associated with frontal lobectomy for right and left frontal lobe glioma 17(Suppl 5, v148-149), 2015. e-Pub 2015.
- Noll KR, Narang S, Martinez J, Rao G, Wefel J, Rao A. Relationships between tumor compartment volumes and neurocognitive functioning in patients with temporal lobe glioma. Neuro-Oncology 17(Suppl 5):v148, 2015. e-Pub 2015.
- Wefel J, Noll K, Rao G, Cahill D. Relationships between neurocognitive functioning and IDH1 genetic mutation status in malignant astrocytoma 16(Suppl 5, v137), 2014. e-Pub 2014.
- Noll K, Garbarino A, Turner C, Verhaak AMS, Wefel J. Depression and executive functioning in relation to survival among patients with glioblastoma 16(Suppl 5, v136), 2014. e-Pub 2014.
- Demeriva P, Noll KR, Sellin J, Prabhu S, Wefel J. Neurocognitive changes associated with frontal lobectomy for right and left frontal lobe glioma. Neuro-Oncology 17(Suppl 5):v148-149, 2014. e-Pub 2014.
- Wefel J, Noll K, Rao G, Cahill D. Relationships between neurocognitive functioning and IDH1 genetic mutation status in malignant astrocytoma. Neuro-Oncology 16(Suppl 5):v137, 2014. e-Pub 2014.
- Noll K, Greenberg BG, Hynan LS, Cullum CM, Taylor S, Harder LL, Lacritz LH. Predictors of quality of life in multiple sclerosis: Relationships between cognitive, physical, and subjective measures of disease burden. The Clinical Neuropsychologist 28:412, 2014. e-Pub 2014.
- Bradshaw ME, Noll K, Ziu M, Weinberg J, Strange C, Turner C, Wefel JS. Neurocognitive functioning and functional status in patients with glioma of the temporal lobes 15(Suppl 3, iii92), 2013. e-Pub 2013.
- Turner C, Strange C, Witgert M, Noll K, Wefel JS. Quality of life, mood, and neurocognitive functioning in patients with temporal lobe glioma. Neuro-Oncology 15(Suppl 3):III96, 2013. e-Pub 2013.
- Ziu M, Noll K, Weinberg J, Benveniste R, Turner C, Strange C, Suki D, Wefel JS. Neurocognitive functioning in patients with glioma of the right and left temporal lobes 15(Suppl 3, iii97), 2013. e-Pub 2013.
- Noll K, Weinberg J, Ziu M, Turner C, Strange C, Wefel JS. Verbal learning and encoding strategies in patients with glioma of the right and left temporal lobes 15(Suppl 3, iii95), 2013. e-Pub 2013.
- Ziu M, Noll K, Weinberg J, Benveniste R, Turner C, Strange C, Suki D, Wefel JS. Neurocognitive functioning in patients with glioma of the right and left temporal lobes. Neuro-Oncology 15(Suppl 3):iii97, 2013. e-Pub 2013.
- Turner C, Strange C, Witgert M, Noll K, Wefel JS. Quality of life, mood, and neurocognitive functioning in patients with temporal lobe glioma 15(Suppl 3, iii96), 2013. e-Pub 2013.
- Noll K, Weinberg J, Ziu M, Turner C, Strange C, Wefel JS. Verbal learning and encoding strategies in patients with glioma of the right and left temporal lobes. Neuro-Oncology 15(Suppl 3):iii95, 2013. e-Pub 2013.
- Wiechmann A, Ritter A, Noll K, Taylor S, Greenberg B, Lacritz L. Test-retest reliability and practice effects of the Symbol Digit Modality Test in patients with demyelinating disease. Journal of the International Neuropsychological Society 18(Suppl 1):23, 2012. e-Pub 2012.
- Noll K, Denney D, Taylor S, Greenberg B, Frohman E, Lacritz L. Relationships between retinal nerve fiber thickness and cognitive and motor functioning in multiple sclerosis. Journal of the International Neuropsychological Society 18(Suppl 1):23, 2012. e-Pub 2012.
- Noll K, Denney D, Taylor S, Greenberg B, Frohman E, Lacritz L. Relationships between retinal nerve fiber thickness and cognitive and motor functioning in multiple sclerosis 18(Suppl 1):23, 2012. e-Pub 2012.
- Wiechmann A, Ritter A, Noll K, Taylor S, Greenberg B, Lacritz L. Test-retest reliability and practice effects of the Symbol Digit Modality Test in patients with demyelinating disease 18(Suppl 1):23, 2012. e-Pub 2012.
- Wiechmann A, Carter K, Noll K, Lacritz L, Cullum CM. An alternate form of the Texas Card Sorting Test: A Pilot Study. Journal of the International Neuropsychological Society 18(Suppl 1):23, 2012. e-Pub 2012.
- Wiechmann A, Carter K, Noll K, Lacritz L, Cullum CM. An alternate form of the Texas Card Sorting Test: A Pilot Study 18(Suppl 1):23, 2012. e-Pub 2012.
- Denney D, Noll K, Lacritz LH. Dyadic short forms of the Wechsler Adult Intelligence Scales-IV for estimating FSIQ and GAI 17(Suppl 1):284, 2011. e-Pub 2011.
- Noll K, Denney D, Wiechman A, Taylor S, Greenberg B, Lacritz LH. Comparison of short and standard form CVLT-II performances in a demyelinating disease population. Archives of Clinical Neuropsychology 26:c-36, 2011. e-Pub 2011.
- Taylor SL, Noll K, Courtney A, Graves D, Frohman E, Mealy M, Lacritz L, Greenberg B. Lack of the PASAT, SDMT, or Judgment of Line tests to detect cognitive impairment in a cohort with demyelinating disease. Neurology 76(9):A485, 2011. e-Pub 2011.
- Denney D, Noll K, Lacritz LH. Dyadic short forms of the Wechsler Adult Intelligence Scales-IV for estimating FSIQ and GAI. Journal of the International Neuropsychological Society 17(Suppl 1):284, 2011. e-Pub 2011.
- Noll K, Cullum CM, O'Bryant S, Hall J, Simpson C, Lacritz LH. Normative data for logical memory story A in Alzheimer’s disease and normal controls. Arch Clin Neuropsychol 25:c-52, 2010. e-Pub 2010.
- Arenivas A, Rossetti H, Rogerson M, Noll K, Lacritz L. Victoria Stroop test performance in multiple sclerosis, Parkinson’s disease, and Alzheimer’s disease. J Int Neuropsychol Soc 16(Suppl 1):192, 2010. e-Pub 2010.
- Arenivas A, Rossetti H, Rogerson M, Noll K, Lacritz L. Victoria Stroop test performance in multiple sclerosis, Parkinson’s disease, and Alzheimer’s disease 16(Suppl 1):192, 2010. e-Pub 2010.
Book Chapters
- Kim M, Gabel N, Noll K, Compter A, Schagen S, Wefel J. Neurocognitive effects. In: Hellman and Rosenberg's Cancer: Principles and Practice of Oncology. Lippincott Williams & Wilkins, 2022.
- Sabsevitz D, Elverman K, Noll K, Wefel J. Neuropsychologist's role in the management of brain tumor patients. In: Brain Mapping: Indications and Techniques. Thieme Publishers, 2020.
- Noll K, Sabsevitz D, Prabhu S, Wefel J. Neuropsychology in the neurosurgical management of primary brain tumors. In: Neurosurgical Neuropsychology. Elsevier, 2018.
- Noll K, Wefel J. Quality of Life and Neurocognitive Function. In: Neuro-Oncology: The Essentials. 3rd. Thieme, 2014.
- Noll K, Lacritz LH. Multiple sclerosis: Psychosocial factors. In: The Encyclopedia of Behavioral Medicine. Springer, 2013.
- Noll K, Barisa M. Paroxysmal Hemicrania. In: The Encyclopedia of Neuropsychological Disorders. Springer, 2010.
- Noll KR. New Neurosurgery.
- Noll KR. New Bernstein.
Patient Reviews
CV information above last modified October 10, 2025